Chronic Kidney Disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: -CKD Patients who newly prescribed Kremezin. -Male/female age over 20 who speak Japanese fluently -Ambulatory patients who are in stable condition and show no risk to be hospitalized. -Patient who sign agreement of this clinical study.
Exclusion criteria
Exclusion criteria: -Hospitalized patinets -Patients who Plannded to undergo artificial dialysis -Patients who have alergic history to Kremezin -Patients who need to pay physician's or nurces's close attention to their illness conditition. -Patients who have cognitive impairment, perceptual disfunction, alcohol addiction, or any other illnesses which incure problems to complete this clinical study. -Patients who have severe heart, liver, or lung disease, mental disorder, or malignant neoplasm progression
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| -The ratio of failure in taking medication by forgetfulness -The ratio of taken drugs in total amont of prescription proved by pill count | — |
Secondary
| Measure | Time frame |
|---|---|
| -Serum creatinine level, Glomerular filtration rate (GFR), urinary protein, Serum Indoxyl Sulfate -Patient behavioral stage according to transtheoretical model -Influence factors on medcation adherence -Satisfaction with adherence support programe | — |
Countries
Japan
Contacts
Juntendo University. Faculty of Medicine Department of Nephrology